RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness.
RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness.
复制标题
DOI:
10.1016/j.devcel.2021.04.022
复制
发表时间:
2021-06-21
影响因子:
11.8
通讯作者:
Gonzalez-Suarez E
中科院分区:
文献类型:
--
作者:
Benítez S;Cordero A;Santamaría PG;Redondo-Pedraza J;Rocha AS;Collado-Solé A;Jimenez M;Sanz-Moreno A;Yoldi G;Santos JC;De Benedictis I;Gómez-Aleza C;Da Silva-Álvarez S;Troulé K;Gómez-López G;Alcazar N;Palmero I;Collado M;Serrano M;Gonzalez-Suarez E
Rank signaling enhances stemness in mouse and human mammary epithelial cells (MECs) and mediates mammary tumor initiation. Mammary tumors initiated by oncogenes or carcinogen exposure display high levels of Rank and Rank pathway inhibitors have emerged as a new strategy for breast cancer prevention and treatment. Here, we show that ectopic Rank expression in the mammary epithelia unexpectedly delays tumor onset and reduces tumor incidence in the oncogene-driven Neu and PyMT models. Mechanistically, we have found that ectopic expression of Rank or exposure to Rankl induces senescence, even in the absence of other oncogenic mutations. Rank leads to DNA damage and senescence through p16/p19. Moreover, RANK-induced senescence is essential for Rank-driven stemness, and although initially translates into delayed tumor growth, eventually promotes tumor progression and metastasis. We uncover a dual role for Rank in the mammary epithelia: Rank induces senescence and stemness, delaying tumor initiation but increasing tumor aggressiveness. Rank expression delays mammary tumor onset in oncogene-driven models Activation of Rank signaling induces senescence through p16/p19 Rank-induced senescence in luminal cells increases basal and luminal stemness Rank-induced senescent cells promote mammary tumor growth Rank pathway inhibitors have emerged as therapeutic options for breast cancer prevention and treatment. Benitez et al. show that activation of Rank signaling induces senescence, which paradoxically delays tumor onset and incidence but promotes tumor aggressiveness. Treatment with senolytics eliminates Rank-induced senescent cells, reducing stemness and breast cancer growth.
登录
查看更多内容
影响因子:
78.5
作者:
Collado, Manuel;Serrano, Manuel
通讯作者:
Serrano, Manuel
DOI:
10.1146/annurev-pathol-121808-102144
发表时间:
2010
期刊:
Annual review of pathology
影响因子:
--
作者:
Coppé JP;Desprez PY;Krtolica A;Campisi J
通讯作者:
Campisi J
影响因子:
12.3
作者:
Herschkowitz JI;Simin K;Weigman VJ;Mikaelian I;Usary J;Hu Z;Rasmussen KE;Jones LP;Assefnia S;Chandrasekharan S;Backlund MG;Yin Y;Khramtsov AI;Bastein R;Quackenbush J;Glazer RI;Brown PH;Green JE;Kopelovich L;Furth PA;Palazzo JP;Olopade OI;Bernard PS;Churchill GA;Van Dyke T;Perou CM
通讯作者:
Perou CM
DOI:
10.1073/pnas.92.20.9363
发表时间:
1995-09-26
影响因子:
11.1
作者:
DIMRI, GP;LEE, XH;CAMPISI, J
通讯作者:
CAMPISI, J
影响因子:
5.3
作者:
Gonzalez-Suarez, Eva;Branstetter, Daniel;Dougall, William C.
通讯作者:
Dougall, William C.